Schroder Investment Management Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.64M | Sell |
|
|||||
|
2025
Q1 | $3.29M | Sell |
|
|||||
|
2024
Q4 | $17.3M | Sell |
|
|||||
|
2024
Q3 | $24.3M | Buy |
|
|||||
|
2024
Q2 | $25.5M | Buy |
|
|||||
|
2024
Q1 | $20.7M | Buy |
|
|||||
|
2023
Q4 | $9.95M | Buy |
|
|||||
|
2023
Q3 | $6.48M | Sell |
|
|||||
|
2023
Q2 | $5.97M | Buy |
|
|||||
|
2023
Q1 | $5.65M | Buy |
|
|||||
|
2022
Q4 | $850K | Sell |
|
|||||
|
2022
Q3 | $1.11M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $287K | Buy |
|
|||||
|
2019
Q2 | $245K | Sell |
|
|||||
|
2019
Q1 | $1.25M | Buy |
|
|||||
|
2018
Q4 | $624 | Sell |
|
|||||
|
2018
Q3 | $2.33M | Sell |
|
|||||
|
2018
Q2 | $2.38M | Hold |
|
|||||
|
2018
Q1 | $2.03M | Sell |
|
|||||
|
2017
Q4 | $2.25M | Sell |
|
|||||
|
2017
Q3 | $2.2M | Buy |
|
|||||
|
2017
Q2 | $948K | Hold |
|
|||||
|
2017
Q1 | $856K | Buy |
|
|||||
|
2016
Q4 | $780K | Sell |
|
|||||
|
2016
Q3 | $1.38M | Sell |
|
|||||
|
2016
Q2 | $2.06M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $504K | Buy |
|